Risk Factors for Recovery of Imipenem- or Ceftazidime-Resistant <i>Pseudomonas aeruginosa</i> Among Patients Admitted to a Teaching Hospital in Brazil

Abstract

Our study suggests a definite role for several classes of antimicrobials as risk factors for recovery of IRPA but not for recovery of CRPA. Limiting the use of only imipenem and ceftazidime may not be a wise strategy to contain the spread of resistant P. aeruginosa strains.